基因型检测可以更好地检测人类简单疹病毒中的抗病毒耐药性
Heather L Glasgow1, Haiying Zhu1, Hong Xie1
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, United States.
概括
对人类简单疹病毒 (HSV) 耐药性的基因型检测显示出有希望的结果,但需要改进. 结合基因型和表型测试,可以更准确和更快速地诊断免疫功能低下患者的HSV抗病毒耐药性.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 分子诊断学 分子诊断
背景情况:
- 人类简单疹病毒 (HSV) 的抗病毒耐药性构成了重大的临床挑战,特别是在免疫受损的个体中.
- 目前的HSV耐药性测试依赖于缓慢的,表型的,基于培养的方法,从而导致经验性的治疗决定.
- 对于许多病毒,分子诊断方法是先进的,但HSV耐药性测试落后.
研究的目的:
- 评估HSV基因型抗病毒耐药性测试的性能.
- 为了比较基因型测试与传统的表型斑块减少试验 (PRA).
- 评估基因型与表型HSV耐药性检测的准确性和速度.
主要方法:
- 采用了HSV菌株的全基因组测序.
- 使用了已知的阿西克洛维尔和福斯卡内特抗药突变的数据库.
- 基因型结果与内部和参考实验室的表型PRA对照菌株和临床隔离物进行了比较.
主要成果:
- 基因型和表型测试之间的一致性各不相同,观察到不确定的和不一致的结果.
- 不确定的结果通常是由于不确定的意义 (VUS) 的变异.
- 对表型敏感菌株的不一致结果揭示了潜在的耐药性突变,有时在耐药亚群中,重复测试改善了一致性.
结论:
- 基因型检测,当与表型方法相结合时,可以提高HSV抗病毒耐药性诊断的准确性和速度.
- 突变的基因型背景和病毒培养限制可能会影响表型耐药性测定结果.
- 作为HSV耐药性测试的黄金标准,单独的表型斑块减少试验具有局限性.
更多相关视频
13:22Detection of the Genome and Transcripts of a Persistent DNA Virus in Neuronal Tissues by Fluorescent In situ Hybridization Combined with Immunostaining
Published on: January 23, 2014
18.3K
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.6K
相关概念视频
Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
